In focus
Latest feed
Teva's Strategic Pivot Gains Traction: Innovative Growth Offsets Generics Slide in Q2 2026
The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
The Pharmaceutical Frontier: Biosimilars on the Rise
Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape
